| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |